Diagnosis and treatment of polycystic ovarian syndrome and insulin resistance

被引:12
作者
Fleischman, A
Mansfield, J
机构
[1] Joslin Diabet Ctr, Pediat & Adolescent Sect, Boston, MA 02215 USA
[2] Childrens Hosp, Div Endocrinol, Boston, MA 02115 USA
[3] Childrens Hosp, Div Adolescent Med, Boston, MA 02115 USA
[4] Harvard Univ, Sch Med, Cambridge, MA 02138 USA
来源
PEDIATRIC ANNALS | 2005年 / 34卷 / 09期
关键词
D O I
10.3928/0090-4481-20050901-13
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
PCOS is a complex syndrome that includes clinical and biochemical evidence of hyperandrogenism and hyperinsulinism. Adolescents with PCOS are affected by the diagnosis with both short-term and long-term consequences. Adolescents with PCOS report lower self-esteem and quality of life, based on standard assessments, when compared with age matched peers. These young women also are concerned about future fertility, which may affect psychological well being and health behaviors. In addition, patients with PCOS are at an increased risk for development of insulin resistance, type 2 diabetes, metabolic syndrome, and cardiovascular disease. Therefore, this identified at-risk group requires rigorous evaluation, treatment and long-term counseling and management by healthcare providers.
引用
收藏
页码:733 / +
页数:10
相关论文
共 61 条
[21]   A unique defect in the regulation of visceral fat cell lipolysis in the polycystic ovary syndrome as an early link to insulin resistance [J].
Ek, I ;
Arner, P ;
Rydén, M ;
Holm, C ;
Thörne, A ;
Hoffstedt, J ;
Wahrenberg, H .
DIABETES, 2002, 51 (02) :484-492
[22]   Impaired adipocyte lipolysis in nonobese women with the polycystic ovary syndrome: A possible link to insulin resistance? [J].
Ek, I ;
Arner, P ;
Bergqvist, A ;
Carlstrom, K ;
Wahrenberg, H .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1997, 82 (04) :1147-1153
[23]   Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS) [J].
Fauser, BCJM ;
Chang, J ;
Azziz, R ;
Legro, R ;
Dewailly, D ;
Franks, S ;
Tarlatzis, BC ;
Fauser, B ;
Balen, A ;
Bouchard, P ;
Dahlgren, E ;
Devoto, L ;
Diamanti, E ;
Dunaif, A ;
Filicori, M ;
Homburg, R ;
Ibanez, L ;
Laven, J ;
Magoffin, D ;
Nestler, J ;
Norman, RJ ;
Pasquali, R ;
Pugeat, M ;
Strauss, J ;
Tan, S ;
Taylor, A ;
Wild, R ;
Wild, S ;
Ehrmann, D ;
Lobo, R .
HUMAN REPRODUCTION, 2004, 19 (01) :41-47
[24]   Ovarian function and metabolic factors in women with oligomenorrhea treated with metformin in a randomized double blind placebo-controlled trial [J].
Fleming, R ;
Hopkinson, ZE ;
Wallace, AM ;
Greer, IA ;
Sattar, N .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (02) :569-574
[25]   Prevalence of the metabolic syndrome among US adults - Findings from the Third National Health and Nutrition Examination Survey [J].
Ford, ES ;
Giles, WH ;
Dietz, WH .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 287 (03) :356-359
[26]  
Gavin JR, 1997, DIABETES CARE, V20, P1183
[27]  
Genuth S, 2003, DIABETES CARE, V26, P3160
[28]   Incidence and treatment of metabolic syndrome in newly referred women with confirmed polycystic ovarian syndrome [J].
Glueck, CJ ;
Papanna, R ;
Wang, P ;
Goldenberg, N ;
Sieve-Smith, L .
METABOLISM-CLINICAL AND EXPERIMENTAL, 2003, 52 (07) :908-915
[29]   Metformin to restore normal menses in oligo-amenorrheic teenage girls with polycystic ovary syndrome (PCOS) [J].
Glueck, CJ ;
Wang, P ;
Fontaine, R ;
Tracy, T ;
Sieve-Smith, L .
JOURNAL OF ADOLESCENT HEALTH, 2001, 29 (03) :160-169
[30]   Menstrual disorders in adolescents - Excess androgens and the polycystic ovary syndrome [J].
Gordon, CM .
PEDIATRIC CLINICS OF NORTH AMERICA, 1999, 46 (03) :519-+